PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment PaxlovidInvestorPlace • 06/30/22
Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID™Business Wire • 06/30/22
U.S. to pay $3.2 billion to Pfizer, BioNTech for more COVID-19 vaccines for fallMarket Watch • 06/29/22
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 VaccineBusiness Wire • 06/29/22
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surgesMarket Watch • 06/28/22
Pfizer booster improved to fight omicron, as hospitalizations rise to 3-month highMarket Watch • 06/27/22
Pfizer/BioNTech's Updated Omicron-Based COVID-19 Shots Show Improved Response Against VariantBenzinga • 06/27/22
Pfizer says updated COVID-19 booster can provide more protection against super-contagious omicronMarket Watch • 06/27/22
Why Pfizer and Moderna Would Profit As CDC Recommends Covid Vaccine For ToddlersThe Dog of Wall Street • 06/25/22